Wuhan Wei Ke Medical Technology Co.
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- Undisclosed
Investors
- 4
About Wuhan Wei Ke Medical Technology Co.
, Ltd is a medical company that focuses on researching and developing the therapies of structural heart disease. The company has applied for 35 patents, including 29 invention patents, 5 utility model patents, and 1 PCT patent. As of 2021, the company has 3,000 square meters of office buildings, a shared industry incubation platform with 10,000 square meters of GMP workshops, and 10,000-level laminar flow clean workshops. The company's main business is research and development, technical services, production, and sales of three types of medical devices. The company's self-developed products include atrial shunt, cardiac occluder delivery system, nanomembrane patent foramen ovale occluder, and atrial septal puncture system.
Who invested in Wuhan Wei Ke Medical Technology Co.
4 investors across 3 rounds
See all investors in Wuhan Wei Ke Medical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Wuhan Wei Ke Medical Technology Co.
Who invested in Wuhan Wei Ke Medical Technology Co.?
Wuhan Wei Ke Medical Technology Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Wuhan Wei Ke Medical Technology Co. raised?
Wuhan Wei Ke Medical Technology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Wuhan Wei Ke Medical Technology Co. last raise money?
Wuhan Wei Ke Medical Technology Co.'s most recent round on record is a Series B, in Dec 2021.
What does Wuhan Wei Ke Medical Technology Co. do?
, Ltd is a medical company that focuses on researching and developing the therapies of structural heart disease.
Where is Wuhan Wei Ke Medical Technology Co. headquartered?
Wuhan Wei Ke Medical Technology Co. is headquartered in Wuhan, China.
Which VCs invest in companies like Wuhan Wei Ke Medical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at Wuhan Wei Ke Medical Technology Co.'s stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Wuhan Wei Ke Medical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.